Skip to main content
Delfa

← Trials/Trial dossier/NCT00530478

UnknownPhase NA

Effect of Donepezil on the Reorganization of Cognitive Neural Network in Patients With Post-Stroke Cognitive Impairment

Asset

Donepezil

Listed sites

1

Recruiting sites

1

Enrollment

-

Study population

Vascular cognitive impairment / dementia

Key I/E criterion

•Age 16-80

Primary endpoint

-

Footprint

Where this trial recruits

Site locations as reported to ClinicalTrials.gov. Site count is not enrollment count; per-site enrollment is not available from source.

Identifiers

Registered as

Org study ID2006-04-023
NCT IDNCT00530478

Timeline

Milestones

Study first posted2007-09-17estimated
Last update posted2007-09-17estimated

Assets

Drug assets

Donepezil

Study populations

Who this study enrolls

Vascular cognitive impairment / dementia

Eligibility

Who can enroll

Minimum age16 Years
Maximum age80 Years
SexAll

Inclusion criteria

•Ischemic stroke in the territory of right or left middle cerebral artery
•Post-onset duration of the recent-onset stroke is over 3 months
•Cognitive deficit ranged from 10 to 26 by minimal mental status examination (MMSE) score
•Disturbance in activities of daily living (ADL) ranged 0.5 ~ 2.0 by clinical dementia rating (CDR) scale

Exclusion criteria

•Severe internal carotid artery stenosis on the lesion side
•Cardiac pacemaker or intracranial metal insertion
•Post-stroke seizure disorder or any evidence of epileptic spikes on electroencephalography (EEG)

Endpoints (0)

What's being measured

Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.

No endpoints recorded for this trial.

Provenance

Sources

Trial identity, design, statusClinicalTrials.gov API v2
Snapshot dateJuly 21, 2026
Endpoint classificationDelfa ADRD endpoint taxonomy
Results tableno registry results posted yet

Trial facts come from public ClinicalTrials.gov records. Endpoint categories are Delfa's classification of those records, not a ClinicalTrials.gov field. All figures reflect the July 21, 2026 snapshot.